A Danish study of more than 6,000 heart failure patients found that those who take a high dose of losartan have the same risk of dying as those taking a high dose of candesartan. The risk of death, however, is higher among heart failure patients who take low- or medium-dose losartan. The findings appear in the Journal of the American Medical Association.

Related Summaries